MARKSANS PHARMA SHARE PRICE

Marksans Pharma Limited is a pharmaceutical company and has a market capitalization of Rs. 2,916 crores as of 18th August 2021. The company started on 16th April 1992. The company has reported a total quarterly income of Rs.354.84 crores at the end of June 2021. The Bombay Stock Exchange (BSE) and National Stock Exchange have assigned the number 524404 and scrip code MARKSANS. As of 18th August 2021, Marksans Pharma’s shares were trading at Rs. 71.25.

The corporate is engaged in the research, manufacturing, and marketing of generic pharmaceutical formulations. The company’s research and development centres are in Verna Goa and Navi Mumbai, respectively. With three manufacturing facilities in India, UK, and therefore the US, Marksans has established an authoritative position in regulated markets in India and abroad. The company currently has approximately 1200 employees globally with more than 500 registered products. It also has 50+ experienced scientists in the R& D facility. The promoter holding stood at 48.25% in June 2021 and has remained constant over the last 15 months. Promoters have zero pledged holdings.

In June 2021, the company reported total revenue of Rs. 354.84 crores as compared to Rs. 336.21 crores during the quarter ended March 2021. It had posted net profit / (loss) of Rs. 62.60 crores for the period ended June 2021 as compared to net profit / (loss) of Rs.79.49 crores for the period ended 31st March 2021. The company’s EPS was at Rs.1.51 for the period ended 30th June '2021, as against Rs.1.93 for the period ended 31st March '2021. On a year-on-year basis, the total income of the company has increased 7.10% from Rs. 331.33 crores to Rs. 354.84 crores with the net profit increasing 26.82% from Rs. 49.36 crores to Rs. 62.60 crores and with EPS increasing 25.83% to Rs. 1.51 as against Rs. 1.2 in June 2020. Over the last 5 years, the company’s market share has increased from 0.49% to 0.54%. Marksans Pharma’s shares closed at Rs. 71.25 (NSE) as of 18th August 2021 and has given a return of 30.38% over the last 12 months.

Marksans Pharma share price as on 05 Dec 2025 is Rs. 186.26. Over the past 6 months, the Marksans Pharma share price has decreased by 27.47% and in the last one year, it has decreased by 46.01%. The 52-week low for Marksans Pharma share price was Rs. 162 and 52-week high was Rs. 358.55.

Marksans Pharma Limited is a pharmaceutical company and has a market capitalization of Rs. 2,916 crores as of 18th August 2021. The company started on 16th April 1992. The company has reported a total quarterly income of Rs.354.84 crores at the end of June 2021. The Bombay Stock Exchange (BSE) and National Stock Exchange have assigned the number 524404 and scrip code MARKSANS. As of 18th August 2021, Marksans Pharma’s shares were trading at Rs. 71.25.

The corporate is engaged in the research, manufacturing, and marketing of generic pharmaceutical formulations. The company’s research and development centres are in Verna Goa and Navi Mumbai, respectively. With three manufacturing facilities in India, UK, and therefore the US, Marksans has established an authoritative position in regulated markets in India and abroad. The company currently has approximately 1200 employees globally with more than 500 registered products. It also has 50+ experienced scientists in the R& D facility. The promoter holding stood at 48.25% in June 2021 and has remained constant over the last 15 months. Promoters have zero pledged holdings.

In June 2021, the company reported total revenue of Rs. 354.84 crores as compared to Rs. 336.21 crores during the quarter ended March 2021. It had posted net profit / (loss) of Rs. 62.60 crores for the period ended June 2021 as compared to net profit / (loss) of Rs.79.49 crores for the period ended 31st March 2021. The company’s EPS was at Rs.1.51 for the period ended 30th June '2021, as against Rs.1.93 for the period ended 31st March '2021. On a year-on-year basis, the total income of the company has increased 7.10% from Rs. 331.33 crores to Rs. 354.84 crores with the net profit increasing 26.82% from Rs. 49.36 crores to Rs. 62.60 crores and with EPS increasing 25.83% to Rs. 1.51 as against Rs. 1.2 in June 2020. Over the last 5 years, the company’s market share has increased from 0.49% to 0.54%. Marksans Pharma’s shares closed at Rs. 71.25 (NSE) as of 18th August 2021 and has given a return of 30.38% over the last 12 months.

Marksans Pharma share price as on 05 Dec 2025 is Rs. 186.26. Over the past 6 months, the Marksans Pharma share price has decreased by 27.47% and in the last one year, it has decreased by 46.01%. The 52-week low for Marksans Pharma share price was Rs. 162 and 52-week high was Rs. 358.55.